Last edition
News about Global Pharma
Sanofi to Acquire Dren Bio Bispecific Myeloid Cell Engager for Deep B-Cell Depletion
DR-0201 is a potential first-in-class CD20-directed bispecific antibody that targets and engages specific tissue-resident and trafficking myeloid cells to induce deep B-cell depletion via targeted phagocytosis.
Global Pharma | 24/03/2025 | By Aishwarya | 197
BrePco and Piramal Receive UK MHRA Approval for Neoatricon Paediatric Dopamine Formula
Neoatricon, developed by BrePco Biopharma, is an age-appropriate, ready-to-use, sterile solution available in two concentrations: 1.5 mg/mL in a 30 mL vial and a higher strength of 4.5 mg/mL in a 50 mL vial.
Global Pharma | 24/03/2025 | By Aishwarya | 322
Syneron Bio Signs Strategic Partnership with AstraZeneca
Under this collaboration, AstraZeneca will gain access to Syneron Bio's innovative Synova™ platform, an intelligent and high-throughput macrocyclic peptide drug research and development platform, designed to support the advancements of research programmes exploring possible future treatments of chronic diseases.
Global Pharma | 24/03/2025 | By Aishwarya | 956
Hansoh Pharma Expands Indications for Merigolix with Initiation of ART Development
Hansoh Pharma recently received approval for an IND (Investigational New Drug) application targeting ART, expanding the development area of merigolix.
Global Pharma | 21/03/2025 | By Aishwarya | 385
Pint Pharma Gets ANVISA Approval of BESREMi for Polycythemia Vera
Polycythemia Vera (PV) is a rare, chronic, debilitating, and potentially fatal myeloproliferative neoplasm, originating from a disease-initiating stem cell in the bone marrow.
Global Pharma | 21/03/2025 | By Aishwarya | 564
Grifols and Inpeco to Deliver Transfusion Medicine Labs
Grifols, whose technology analyzes tens of millions of donor samples each year, now complements its portfolio with Inpeco’s new open automation system FlexLab™ X, a combination of leading-edge robotics and software that will enable Grifols solutions to interconnect with, and expand within, existing and future lab footprints.
Global Pharma | 21/03/2025 | By Aishwarya | 228
Advanced Instruments Plans to Acquire and Merge Nova Biomedical
Following the closing of the transaction, Advanced Instruments and Nova Biomedical will merge, creating a global life science tools platform that will operate under the Nova Biomedical name, with a diversified portfolio of analytical instruments, reagents and services.
Global Pharma | 20/03/2025 | By Aishwarya | 304
Supriya Lifescience Inaugurates New 5 MWp Solar Facility in Maharashtra
This initiative is part of the ongoing program in which Supriya Lifesciences is committed to reducing carbon footprint from its operations.
Global Pharma | 20/03/2025 | By Aishwarya | 538
Indegene Inaugurates New Center in London to Expand Globally
Indegene’s Europe-based clients can now benefit from this center as a strategic hub for consulting and commercialization solutions and modernize their operations with an AI-first approach.
Global Pharma | 20/03/2025 | By Aishwarya | 334
Marksans Pharma’s UK subsidiary Relonchem has received UK MHRA approval for Baclofen 10 mg tablets, strengthening its presence in the UK pharmaceutical market.
Global Pharma | 19/03/2025 | By Manvi | 783
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy